Novavax COVID-19 Vaccine—A Possibly Safer Choice but Likely Obsolete
THE MCCULLOUGH REPORT - Ein Podcast von Dr. Peter McCullough - Montags
Kategorien:
The technology differs from Pfizer and Moderna’s shots, which were the first ones using messenger RNA technology to receive FDA approval and have resulted in catastrophic rates of injury, disability, and death. In the Novavax clinical trial experience, there were no hospitalizations or deaths due to COVID-19...
